High Prevalence of Claudin 18.2 Expression in Japanese Patients with Gastric Cancer.

被引：3
|
作者：
Tureci, Ozlem
Itoh, Kyogo
Yamaguchi, Rin
Mukhina, Svetlana
Sahin, Ugur
Rohde, Christoph
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15584
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Clinicopathologic and molecular characterization of stages II-IV gastric cancer with Claudin 18.2 expression
    Kwak, Yoonjin
    Kim, Tae-Yong
    Nam, Soo Kyung
    Hwang, Hye Jung
    Han, Daeyoung
    Oh, Hyeon Jeong
    Kong, Seong-Ho
    Park, Do Joong
    Oh, Do-Youn
    Lee, Hyuk-Joon
    Im, Seock-Ah
    Yang, Han-Kwang
    Lee, Hye Seung
    ONCOLOGIST, 2024,
  • [22] Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer:A retrospective study
    Changsong Qi
    Xiaoyi Chong
    Ting Zhou
    Mingyang Ma
    Jifang Gong
    Miao Zhang
    Jian Li
    Jun Xiao
    Xiaohui Peng
    Zhen Liu
    Zonghai Li
    Lin Shen
    Xiaotian Zhang
    Chinese Journal of Cancer Research, 2024, 36 (01) : 78 - 95
  • [23] Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer
    Kubota, Y.
    Kawazoe, A.
    Mishima, S.
    Nakamura, Y.
    Kotani, D.
    Kuboki, Y.
    Bando, H.
    Kojima, T.
    Doi, T.
    Yoshino, T.
    Kuwata, T.
    Shitara, K.
    ESMO OPEN, 2023, 8 (01)
  • [24] Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study
    Qi, Changsong
    Chong, Xiaoyi
    Zhou, Ting
    Ma, Mingyang
    Gong, Jifang
    Zhang, Miao
    Li, Jian
    Xiao, Jun
    Peng, Xiaohui
    Liu, Zhen
    Li, Zonghai
    Shen, Lin
    Zhang, Xiaotian
    CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36 (01)
  • [25] PREVALENCE OF CLAUDIN18.2 AND PD-L1 EXPRESSION IN CHINESE GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
    Mao, Linlin
    Yi, Wei
    Lin, Xu-Alan
    Gu, Ying
    Xia, Zhenzhong
    Qi, Chuan
    Shi, Michael
    Yu, Steven
    Qian, Xueming
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A115 - A115
  • [26] Evaluation and reflection on claudin 18.2 targeting therapy in advanced gastric cancer
    Zhang, Jianwei
    Dong, Ruilan
    Shen, Lin
    CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (02) : 263 - 270
  • [27] Claudin 18.2-a FAST-moving target in gastric cancer?
    Athauda, A.
    Chau, I.
    ANNALS OF ONCOLOGY, 2021, 32 (05) : 584 - 586
  • [28] DEVELOPMENT OF CLAUDIN 18.2 TAC T CELLS FOR THE TREATMENT OF GASTRIC CANCER
    Helsen, Christopher
    Benatar, Tania
    Philbert, I. P.
    Xu, Stacey
    Shaver, Laura
    Nitya-Nootan, Thanyashanthi
    Bader, Andreas
    Lal, Prabha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A127 - A127
  • [29] Evaluation and reflection on claudin 18.2 targeting therapy in advanced gastric cancer
    Jianwei Zhang
    Ruilan Dong
    Lin Shen
    ChineseJournalofCancerResearch, 2020, 32 (02) : 263 - 270
  • [30] Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer
    Kubota, Yohei
    Shitara, Kohei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
12345